Brief: Spectrum Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
17/05/2023 12:00
May 17 (Reuters) - Spectrum Pharmaceuticals Inc
SPPI.O :
* SPECTRUM PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ
MINIMUM
BID PRICE REQUIREMENT
Source text for Eikon: ID:nBw45d1Tga
Further company coverage: SPPI.O
Recent news on Spectrum Pharmaceuticals
See all newsBrief: Assertio Holdings Announces Favorable Vote On Proposed Acquisition Of Spectrum Pharmaceuticals
Brief: Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “For” Proposed Deal With Assertio Holdings, Inc.
Brief: Spectrum Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
Spectrum Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary